Influence of Osteoporosis on the Course of Apical Periodontitis

Overview

Journal Eur J Dent

Publisher Thieme

Specialty Dentistry

Date 2024 May 17

PMID 38759999

Authors

Evgeni Stanev

Radosveta Ivanova Vasileva

Affiliations

Soon will be listed here.

Abstract

Osteoporosis is a disease characterized by disruption of the bone microarchitecture. It is observed in both sexes, but to a greater extent in women. It affects the whole body, including the jaws. The main indicator of the presence of osteoporosis accepted by the World Health Organization is bone mineral density. The aim of this article is to find data on the influence of osteoporosis on apical periodontitis, to investigate how the intake of osteoporosis drugs affects apical periodontitis, and to establish various data that may be of benefit to the dental practitioner when treating patients with osteoporosis and apical periodontitis. Open-access publications are included. The presence of osteoporosis is important to the dentist. Apical periodontitis in these patients has a faster progression. They are characterized by inflammation and destruction of the tissues located around the tooth root. Osteoporosis has a destructive effect on bone tissue through different mechanisms: nuclear factor-κβ ligand and NLRP3/Caspase-1/IL-1β cascade. It is also associated with low estrogen levels. Various medications such as corticosteroids, bisphosphonates (alendronate, zoledronate (Zoledronic acid), calcitonin, raloxifene, and strontium used to treat osteoporosis can affect the course of apical periodontitis. When treating patients with periapical lesions, the dentist must take a proper medical history and general medical history. In cases of osteoporosis or taking bisphosphonates and other medications, consideration should be given to whether consultation with a specialist is necessary, what treatment approach would be most appropriate, and what the prognosis will be. Chronic diseases affect both the general state of the body and dental health. It has been found that in patients with osteoporosis, inflammation of the apical periodontium develops with faster bone resorption. Before starting dental treatment, it is important to specify the etiology of osteoporosis, the bone density of each patient, as well as the medications they are taking.

References

Maia C, Chaves H, Benetti F, de Menezes G, Antunes M, Pinto K . Zoledronic Acid Modulates Cytokine Expression and Mitigates Bone Loss during the Development of Induced Apical Periodontitis in a Mice Model. J Endod. 2023; 49(11):1522-1528. DOI: 10.1016/j.joen.2023.08.010. View

Oztekin F, Gurgenc T, Dundar S, Ozercan I, Talo Yildirim T, Eskibaglar M . In Vivo Evaluation of the Effects of B-Doped Strontium Apatite Nanoparticles Produced by Hydrothermal Method on Bone Repair. J Funct Biomater. 2022; 13(3). PMC: 9397061. DOI: 10.3390/jfb13030110. View

Compston J, Bowring C, Cooper A, Cooper C, Davies C, Francis R . Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013. Maturitas. 2013; 75(4):392-6. DOI: 10.1016/j.maturitas.2013.05.013. View

Tuzun S, Eskiyurt N, Akarirmak U, Saridogan M, Senocak M, Johansson H . Incidence of hip fracture and prevalence of osteoporosis in Turkey: the FRACTURK study. Osteoporos Int. 2011; 23(3):949-55. DOI: 10.1007/s00198-011-1655-5. View

Qian H, Jia J, Yang Y, Bian Z, Ji Y . A Follicle-Stimulating Hormone Exacerbates the Progression of Periapical Inflammation Through Modulating the Cytokine Release in Periodontal Tissue. Inflammation. 2020; 43(4):1572-1585. DOI: 10.1007/s10753-020-01234-9. View

Kainat R, Ahmed I, Alolaywi A, Waheed H, Sultan Z, Moin S . Assessment of Salivary MMP-8 and IL-1β for the Diagnosis of Periodontal Diseases in Pakistani Population. Eur J Dent. 2023; 18(2):672-679. PMC: 11132764. DOI: 10.1055/s-0043-1772779. View

Jobke B, Milovanovic P, Amling M, Busse B . Bisphosphonate-osteoclasts: changes in osteoclast morphology and function induced by antiresorptive nitrogen-containing bisphosphonate treatment in osteoporosis patients. Bone. 2013; 59:37-43. DOI: 10.1016/j.bone.2013.10.024. View

Hsiao A, Glickman G, He J . A retrospective clinical and radiographic study on healing of periradicular lesions in patients taking oral bisphosphonates. J Endod. 2009; 35(11):1525-8. DOI: 10.1016/j.joen.2009.07.020. View

Grigoriadis A, Raisanen I, Parnanen P, Tervahartiala T, Sorsa T, Sakellari D . Is There a Link between COVID-19 and Periodontal Disease? A Narrative Review. Eur J Dent. 2022; 16(3):514-520. PMC: 9507582. DOI: 10.1055/s-0041-1740223. View

10.

Lopez-Lopez J, Castellanos-Cosano L, Estrugo-Devesa A, Gomez-Vaquero C, Velasco-Ortega E, Segura-Egea J . Radiolucent periapical lesions and bone mineral density in post-menopausal women. Gerodontology. 2013; 32(3):195-201. DOI: 10.1111/ger.12076. View

11.

Gomes-Filho J, Wayama M, Dornelles R, Ervolino E, Yamanari G, Lodi C . Raloxifene modulates regulators of osteoclastogenesis and angiogenesis in an oestrogen deficiency periapical lesion model. Int Endod J. 2014; 48(11):1059-68. DOI: 10.1111/iej.12403. View

12.

Cadoni E, Ideo F, Marongiu G, Mezzena S, Frigau L, Mela Q . Periapical status in patients affected by osteoporosis: A retrospective clinical study. Clin Exp Dent Res. 2022; 8(5):1068-1075. PMC: 9562578. DOI: 10.1002/cre2.604. View

13.

Elsayed Ramadan D, Hariyani N, Indrawati R, Ridwan R, Diyatri I . Cytokines and Chemokines in Periodontitis. Eur J Dent. 2020; 14(3):483-495. PMC: 7440949. DOI: 10.1055/s-0040-1712718. View

14.

Lilakhunakon C, Suwanpateeb J, Patntirapong S . Inhibitory Effects of Alendronate on Adhesion and Viability of Preosteoblast Cells on Titanium Discs. Eur J Dent. 2021; 15(3):502-508. PMC: 8382445. DOI: 10.1055/s-0041-1726170. View

15.

Cosman F, de Beur S, LeBoff M, Lewiecki E, Tanner B, Randall S . Clinician's Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int. 2014; 25(10):2359-81. PMC: 4176573. DOI: 10.1007/s00198-014-2794-2. View

16.

Cheng C, Chen L, Chen K . Osteoporosis Due to Hormone Imbalance: An Overview of the Effects of Estrogen Deficiency and Glucocorticoid Overuse on Bone Turnover. Int J Mol Sci. 2022; 23(3). PMC: 8836058. DOI: 10.3390/ijms23031376. View

17.

Woolf A . An update on glucocorticoid-induced osteoporosis. Curr Opin Rheumatol. 2007; 19(4):370-5. DOI: 10.1097/BOR.0b013e328133f5c7. View

18.

Guan X, Guan Y, Shi C, Zhu X, He Y, Wei Z . Estrogen deficiency aggravates apical periodontitis by regulating NLRP3/caspase-1/IL-1β axis. Am J Transl Res. 2020; 12(2):660-671. PMC: 7061852. View

19.

Lucisano M, da Silva R, de Sousa Pereira A, Romualdo P, Feres M, Queiroz A . Alteration of the oral microbiota may be a responsible factor, along with estrogen deficiency, by the development of larger periapical lesions. Clin Oral Investig. 2020; 25(6):3651-3662. DOI: 10.1007/s00784-020-03688-5. View

20.

Brasil S, Santos R, Fernandes A, Alves F, Pires F, Siqueira Jr J . Influence of oestrogen deficiency on the development of apical periodontitis. Int Endod J. 2016; 50(2):161-166. DOI: 10.1111/iej.12612. View